Project Grant HT94252410622
Award Date
6/1/24
Completion Date
5/31/25
Dollars Obligated
$161K
Federal Agency
Defense Health Agency
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...
The Project Grant award, titled "IDENTIFYING NOVEL DRUG TARGETS FOR LETHAL PROSTATE CANCER USING LIQUID BIOPSY," was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,782,155 award to Mayo Clinic will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. This multi-year (4/1/2025 - 3/31/2028) project will investigate innovative approaches to the...
The Mayo Clinic was awarded a $1.7 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research...
The Mayo Clinic received a $278,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to Mayo Clinic provides $1,443,639.00 to investigate the molecular mechanisms underlying the ciliary trafficking of polycystins. The grant has an award date of April 1, 2024 and a planned completion date of March 31, 2028. This research seeks to advance the understanding of diseases related to ciliary dysfunction, which may have important implications for military medicine....
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
The Defense Health Agency awarded a $597,543.00 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, a nonprofit academic medical center. The grant, which runs from October 1, 2023 to September 14, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420) to support research aimed at "elucidating mechanisms of CAR-T cell immunotherapy resistance and sensitivity to improve treatment of myeloma." As a nonprofit organization with...
The U.S. Defense Health Agency has awarded a $1,187,875 Project Grant to Mayo Clinic to support the research project "INVESTIGATING MOLECULAR MECHANISMS UNDERLYING THE CILIARY TRAFFICKING OF POLYCYSTINS". This grant, awarded on April 1, 2024 under the Military Medical Research and Development program (CFDA 12.420), will fund research to advance the understanding of the molecular mechanisms involved in the trafficking of polycystins through cellular cilia. The project aims to yield...
Mayo Clinic will receive $795,000 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct the project "PHARMACODYNAMIC BIOMARKER-GUIDED METABOLIC COLLAPSE OF IDH-MUTANT GLIOMA" from September 2021 through September 2024. This Project Grant aims to develop medical solutions for the battlefield by investigating pharmacodynamic biomarkers to guide targeted metabolic therapies for the treatment of isocitrate...